MeSH
Administration, Intravenous /methods; Cost-Benefit Analysis; Home Care Services; Humans; Immunoglobulin G /administration & Immunologic Deficiency Syndromes /drug therapy; Infusions, Subcutaneous /methods; Quality of Life; Randomized Controlled Trials as Topic; dosage /adverse effects